公司资料

PharmaCyte Biotech 股价、新闻与催化剂

股票代码:
PMCB
交易所:
NASDAQ
行业:
Biopharma
所在地:
United States

股票表现

4.56 USD (-15.08%)

收盘价

最后更新: 2026年11月19日

8.06M USD

市值

股价为何变动

截至 2026年11月19日,PMCB 下跌 15.1%,收于 $4.56。当前新闻监测窗口内未发现新的同公司新闻。

公司概览

业务概览

PharmaCyte Biotech was a biotechnology company focused on cell encapsulation and oncology before its restructuring and public-market decline. Its story centered on an experimental cancer-delivery platform.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ before restructuring, PharmaCyte sat in specialty biotechnology.

商业模式特征

The business depended on clinical validation, platform feasibility, and the chance to convert a niche concept into value.

生物医药行业定位

PharmaCyte belongs to the historical or restructuring biotech set rather than the current live public-company universe.

未来催化剂

  • PharmaCyte is now largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline event. The market is focused on what value remains.

近期新闻

新闻标题由机器翻译,详情为英文原文。

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

相似股票

商业成熟度、治疗领域或催化剂模式相近的同行公司。